World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
42070
World Ranking
9152
National Ranking
105

Jorma Paavonen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jorma Paavonen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 549 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jorma Paavonen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jorma Paavonen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jorma Paavonen is affiliated with the University of Helsinki in Finland and has contributed extensively to research in medicine, particularly within immunology and microbiology. Their work has spanned multiple subfields including epidemiology, microbiology, public health, environmental and occupational health, surgery, and obstetrics and gynecology.

The scientist's research covers various main topics that include:

  • Reproductive tract infections research
  • Cervical cancer and HPV research
  • Hepatitis B virus studies
  • Maternal and perinatal health interventions
  • Genital health and disease
  • Maternal and fetal healthcare
  • Urinary tract infections management

Recent papers authored or co-authored by Jorma Paavonen include:

  • "Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study", 2021, published in Acta Obstetricia Et Gynecologica Scandinavica
  • "Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion", 2022, published in Frontiers in Cellular and Infection Microbiology
  • "Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Number 215", 2020, published in Obstetrics and Gynecology
  • "Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials", 2021, published in The Lancet Infectious Diseases
  • "Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied", 2020, published in The Journal of Infectious Diseases

Frequent co-authors collaborating with Jorma Paavonen include:

  • Matti Lehtinen
  • Vedran Stefanović
  • Minna Tikkanen
  • Tiina Eriksson
  • Robert C. Brunham

The scientist's work is often published in several notable research venues, with multiple publications appearing in:

  • Journal of Perinatal Medicine
  • Frontiers in Cellular and Infection Microbiology
  • The Journal of Infectious Diseases
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Acta Obstetricia Et Gynecologica Scandinavica

Best Publications

  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

    Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen

  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

    J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler

  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud

  • A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

    LA Koutsky;KK Holmes;CW Critchlow;CE Stevens

  • Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

    Lawrence Corey;Anna Wald;Raj Patel;Stephen L. Sacks

  • Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn

  • Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

    Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler

  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade

  • Chlamydia trachomatis: impact on human reproduction

    J Paavonen;W Eggert-Kruse

  • Pelvic Inflammatory Disease

    Robert C Brunham;Sami L Gottlieb;Jorma Paavonen

  • Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Cosette M. Wheeler;Xavier Castellsagué;Suzanne M. Garland;Anne Szarewski

  • Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

    Tarja Anttila;Pekka Saikku;Pentti Koskela;Aini Bloigu

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

    Darron R. Brown;Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen

  • Mucopurulent Cervicitis — The Ignored Counterpart in Women of Urethritis in Men

    Robert C. Brunham;Jorma Paavonen;Claire E. Stevens;Nancy Kiviat

  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    Nubia Munoz;Susanne K. Kjaer;Kristján Sigurdsson;Ole Erik Iversen

  • Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up.

    Ritva Hurskainen;Juha Teperi;Pekka Rissanen;Anna-Mari Aalto

  • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Sven-Eric Olsson;Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta

  • Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

    Elmar A. Joura;Suzanne M. Garland;Suzanne M. Garland;Jorma Paavonen;Daron Gale Ferris

  • Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

    Pentti Koskela;Tarja Anttila;Tone Bjørge;Anne Brunsvig

  • Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.

    Ritva Hurskainen;Juha Teperi;Pekka Rissanen;Anna-Mari Aalto

Frequent Co-Authors

Matti Lehtinen
Matti Lehtinen Tampere University
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Mika Gissler
Mika Gissler Finnish Institute for Health and Welfare
King K. Holmes
King K. Holmes University of Washington
Eero Pukkala
Eero Pukkala Tampere University
Cosette M. Wheeler
Cosette M. Wheeler University of New Mexico
Nancy B. Kiviat
Nancy B. Kiviat University of Washington
David A. Eschenbach
David A. Eschenbach University of Washington
Gary Dubin
Gary Dubin GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s important to explore related online degrees and alternative career routes in healthcare. Many students look for pathways that offer flexibility and specialized focus, allowing them to tailor their education to their career goals.

For those interested in nursing, some programs remove common testing barriers. You may want to consider a nursing school that doesn't require teas, making entry quicker and less stressful.

Administration roles are also in high demand. Completing an online healthcare administration degree can open doors to management positions in hospitals, clinics, and beyond.

Nurses looking for advanced practice roles can enroll in rn to np programs, bridging from an Associate’s Degree in Nursing (ADN) to a Master’s of Science in Nursing (MSN).

Nutrition is another growing field. Earning an online bs in nutrition prepares you for careers in wellness, healthcare, public health, and education.

Exploring these online degrees can help you find the best fit for your ambitions and adapt to the changing needs of the healthcare sector.

Best Scientists Citing Jorma Paavonen

Trending Scientists

Recently Published Articles